HEADER HYDROLASE 17-AUG-17 5QCI TITLE CRYSTAL STRUCTURE OF HUMAN CATHEPSIN-S WITH BOUND LIGAND COMPND MOL_ID: 1; COMPND 2 MOLECULE: CATHEPSIN S; COMPND 3 CHAIN: A; COMPND 4 EC: 3.4.22.27; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CTSS; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS D3R, CATHEPSIN S, LIGAND DOCKING, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR S.D.BEMBENEK,M.K.AMERIKS,T.MIRZADEGAN,H.YANG,C.SHAO,S.K.BURLEY REVDAT 4 17-NOV-21 5QCI 1 REMARK REVDAT 3 10-FEB-21 5QCI 1 AUTHOR JRNL REVDAT 2 21-FEB-18 5QCI 1 REMARK REVDAT 1 20-DEC-17 5QCI 0 JRNL AUTH S.D.BEMBENEK,M.K.AMERIKS,T.MIRZADEGAN,H.YANG,C.SHAO, JRNL AUTH 2 S.K.BURLEY JRNL TITL CRYSTAL STRUCTURE OF HUMAN CATHEPSIN-S WITH BOUND LIGAND JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.18 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.12_2829: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.18 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.04 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.370 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 12917 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.159 REMARK 3 R VALUE (WORKING SET) : 0.158 REMARK 3 FREE R VALUE : 0.193 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.870 REMARK 3 FREE R VALUE TEST SET COUNT : 629 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 28.0454 - 3.4573 1.00 3111 163 0.1363 0.1451 REMARK 3 2 3.4573 - 2.7449 1.00 3071 154 0.1536 0.2049 REMARK 3 3 2.7449 - 2.3982 1.00 3053 169 0.1792 0.2497 REMARK 3 4 2.3982 - 2.1790 1.00 3053 143 0.1957 0.2499 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.210 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 18.860 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 1822 REMARK 3 ANGLE : 0.802 2467 REMARK 3 CHIRALITY : 0.049 242 REMARK 3 PLANARITY : 0.005 315 REMARK 3 DIHEDRAL : 18.024 1055 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5QCI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-AUG-17. REMARK 100 THE DEPOSITION ID IS D_1001401775. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-MAY-06 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 4.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54178 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 944 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12917 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.179 REMARK 200 RESOLUTION RANGE LOW (A) : 28.043 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.89 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.56 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100MM SODIUM ACETATE PH 4.5, 200MM REMARK 280 AMMONIUM ACETATE, 25% PEG 8000. PROTEIN CONCENTRATION 7 MG/ML, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K, PH 4.50 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 39.25250 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 36.77100 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 39.25250 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 36.77100 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 910 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 913 LIES ON A SPECIAL POSITION. REMARK 375 HOH A1118 LIES ON A SPECIAL POSITION. REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ILE A 0 CG1 CG2 CD1 REMARK 470 LYS A 98 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 1020 O HOH A 1053 1.97 REMARK 500 OE1 GLN A 219 O HOH A 901 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 21 55.61 -93.59 REMARK 500 THR A 58 -123.21 -114.29 REMARK 500 ASN A 163 11.87 -147.75 REMARK 500 LYS A 177 105.13 -55.73 REMARK 500 LYS A 202 63.31 -117.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1131 DISTANCE = 5.90 ANGSTROMS REMARK 525 HOH A1132 DISTANCE = 7.72 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 802 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue BJV A 803 DBREF 5QCI A 0 217 UNP P25774 CATS_HUMAN 114 331 SEQADV 5QCI SER A 25 UNP P25774 CYS 139 ENGINEERED MUTATION SEQADV 5QCI LEU A 218 UNP P25774 EXPRESSION TAG SEQADV 5QCI GLN A 219 UNP P25774 EXPRESSION TAG SEQADV 5QCI GLY A 220 UNP P25774 EXPRESSION TAG SEQADV 5QCI GLY A 221 UNP P25774 EXPRESSION TAG SEQADV 5QCI GLY A 222 UNP P25774 EXPRESSION TAG SEQRES 1 A 223 ILE LEU PRO ASP SER VAL ASP TRP ARG GLU LYS GLY CYS SEQRES 2 A 223 VAL THR GLU VAL LYS TYR GLN GLY SER CYS GLY ALA SER SEQRES 3 A 223 TRP ALA PHE SER ALA VAL GLY ALA LEU GLU ALA GLN LEU SEQRES 4 A 223 LYS LEU LYS THR GLY LYS LEU VAL SER LEU SER ALA GLN SEQRES 5 A 223 ASN LEU VAL ASP CYS SER THR GLU LYS TYR GLY ASN LYS SEQRES 6 A 223 GLY CYS ASN GLY GLY PHE MET THR THR ALA PHE GLN TYR SEQRES 7 A 223 ILE ILE ASP ASN LYS GLY ILE ASP SER ASP ALA SER TYR SEQRES 8 A 223 PRO TYR LYS ALA MET ASP GLN LYS CYS GLN TYR ASP SER SEQRES 9 A 223 LYS TYR ARG ALA ALA THR CYS SER LYS TYR THR GLU LEU SEQRES 10 A 223 PRO TYR GLY ARG GLU ASP VAL LEU LYS GLU ALA VAL ALA SEQRES 11 A 223 ASN LYS GLY PRO VAL SER VAL GLY VAL ASP ALA ARG HIS SEQRES 12 A 223 PRO SER PHE PHE LEU TYR ARG SER GLY VAL TYR TYR GLU SEQRES 13 A 223 PRO SER CYS THR GLN ASN VAL ASN HIS GLY VAL LEU VAL SEQRES 14 A 223 VAL GLY TYR GLY ASP LEU ASN GLY LYS GLU TYR TRP LEU SEQRES 15 A 223 VAL LYS ASN SER TRP GLY HIS ASN PHE GLY GLU GLU GLY SEQRES 16 A 223 TYR ILE ARG MET ALA ARG ASN LYS GLY ASN HIS CYS GLY SEQRES 17 A 223 ILE ALA SER PHE PRO SER TYR PRO GLU ILE LEU GLN GLY SEQRES 18 A 223 GLY GLY HET SO4 A 801 5 HET GOL A 802 6 HET BJV A 803 48 HETNAM SO4 SULFATE ION HETNAM GOL GLYCEROL HETNAM BJV N-BENZYL-1-{5-[(2-CHLORO-5-{5-(METHYLSULFONYL)-1-[3- HETNAM 2 BJV (MORPHOLIN-4-YL)PROPYL]-4,5,6,7-TETRAHYDRO-1H- HETNAM 3 BJV PYRAZOLO[4,3-C]PYRIDIN-3-YL}PHENYL)ETHYNYL]-2- HETNAM 4 BJV METHOXYPHENYL}METHANAMINE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 SO4 O4 S 2- FORMUL 3 GOL C3 H8 O3 FORMUL 4 BJV C37 H42 CL N5 O4 S FORMUL 5 HOH *232(H2 O) HELIX 1 AA1 ALA A 24 GLY A 43 1 20 HELIX 2 AA2 SER A 49 SER A 57 1 9 HELIX 3 AA3 THR A 58 GLY A 62 5 5 HELIX 4 AA4 LYS A 64 GLY A 68 5 5 HELIX 5 AA5 PHE A 70 LYS A 82 1 13 HELIX 6 AA6 ASP A 102 LYS A 104 5 3 HELIX 7 AA7 ARG A 120 LYS A 131 1 12 HELIX 8 AA8 HIS A 142 LEU A 147 1 6 HELIX 9 AA9 ASN A 204 ILE A 208 5 5 SHEET 1 AA1 3 VAL A 5 ASP A 6 0 SHEET 2 AA1 3 GLY A 165 LEU A 174 -1 O TYR A 171 N VAL A 5 SHEET 3 AA1 3 VAL A 134 GLY A 137 -1 N VAL A 136 O VAL A 166 SHEET 1 AA2 5 VAL A 5 ASP A 6 0 SHEET 2 AA2 5 GLY A 165 LEU A 174 -1 O TYR A 171 N VAL A 5 SHEET 3 AA2 5 LYS A 177 LYS A 183 -1 O LYS A 183 N LEU A 167 SHEET 4 AA2 5 TYR A 195 ALA A 199 -1 O MET A 198 N TRP A 180 SHEET 5 AA2 5 VAL A 152 TYR A 153 1 N TYR A 153 O ARG A 197 SHEET 1 AA3 2 ILE A 84 ASP A 85 0 SHEET 2 AA3 2 ARG A 106 ALA A 108 -1 O ALA A 107 N ILE A 84 SHEET 1 AA4 2 LYS A 112 GLU A 115 0 SHEET 2 AA4 2 SER A 213 GLU A 216 -1 O TYR A 214 N THR A 114 SSBOND 1 CYS A 22 CYS A 66 1555 1555 2.05 SSBOND 2 CYS A 56 CYS A 99 1555 1555 2.06 SSBOND 3 CYS A 158 CYS A 206 1555 1555 2.03 SITE 1 AC1 11 GLN A 19 GLY A 23 ALA A 24 SER A 25 SITE 2 AC1 11 ASN A 163 HIS A 164 BJV A 803 HOH A 903 SITE 3 AC1 11 HOH A 932 HOH A1027 HOH A1045 SITE 1 AC2 8 LEU A 38 THR A 42 ALA A 108 THR A 109 SITE 2 AC2 8 ARG A 141 PRO A 143 PHE A 146 ILE A 217 SITE 1 AC3 16 LYS A 41 PHE A 70 TYR A 118 ALA A 140 SITE 2 AC3 16 ARG A 141 ASN A 161 VAL A 162 ASN A 163 SITE 3 AC3 16 GLY A 165 ASN A 175 PHE A 211 SO4 A 801 SITE 4 AC3 16 HOH A 913 HOH A 928 HOH A 947 HOH A 960 CRYST1 78.505 73.542 44.655 90.00 103.86 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012738 0.000000 0.003142 0.00000 SCALE2 0.000000 0.013598 0.000000 0.00000 SCALE3 0.000000 0.000000 0.023065 0.00000